Do analysts rate USNA or ODD?

ODDITY Tech has a consensus target price of $25.39, suggesting a potential upside of 69.36%. Given ODDITY Tech's stronger consensus rating and higher probable upside, analysts clearly believe ODDITY Tech is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 ODDITY Tech 4 Sell rating(s) 9 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.69

Does the media refer more to USNA or ODD?

In the previous week, ODDITY Tech had 5 more articles in the media than USANA Health Sciences. MarketBeat recorded 6 mentions for ODDITY Tech and 1 mentions for USANA Health Sciences. ODDITY Tech's average media sentiment score of 0.64 beat USANA Health Sciences' score of 0.00 indicating that ODDITY Tech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment USANA Health Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ODDITY Tech 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer USNA or BWMX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Betterware de Mexico SAPI de C 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Do analysts rate HNST or USNA?

Honest presently has a consensus target price of $4.84, indicating a potential downside of 15.97%. Given Honest's stronger consensus rating and higher probable upside, equities research analysts plainly believe Honest is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Honest 2 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.22 USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor HNST or USNA?

In the previous week, Honest had 20 more articles in the media than USANA Health Sciences. MarketBeat recorded 21 mentions for Honest and 1 mentions for USANA Health Sciences. Honest's average media sentiment score of 0.83 beat USANA Health Sciences' score of 0.00 indicating that Honest is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Honest 13 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive USANA Health Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate USNA or PRE?

Prenetics Global has a consensus target price of $34.80, suggesting a potential upside of 32.57%. Given Prenetics Global's stronger consensus rating and higher probable upside, analysts plainly believe Prenetics Global is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Prenetics Global 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.67

Does the media refer more to USNA or PRE?

In the previous week, Prenetics Global had 35 more articles in the media than USANA Health Sciences. MarketBeat recorded 36 mentions for Prenetics Global and 1 mentions for USANA Health Sciences. Prenetics Global's average media sentiment score of 0.57 beat USANA Health Sciences' score of 0.00 indicating that Prenetics Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment USANA Health Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Prenetics Global 7 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend YSG or USNA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Yatsen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer YSG or USNA?

In the previous week, Yatsen had 1 more articles in the media than USANA Health Sciences. MarketBeat recorded 2 mentions for Yatsen and 1 mentions for USANA Health Sciences. Yatsen's average media sentiment score of 0.50 beat USANA Health Sciences' score of 0.00 indicating that Yatsen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Yatsen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive USANA Health Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

USANA Health Sciences (USNA) Competitors

$14.07 +0.40 (+2.93%)

Closing price 08/27/2026 03:59 PM Eastern

Extended Trading

$14.09 +0.02 (+0.16%)

As of 08/27/2026 08:00 PM Eastern

Compare

USNA vs. ODD, BWMX, HNST, PRE, and YSG

Should you buy USANA Health Sciences stock or one of its competitors? USANA Health Sciences's main competitors and comparable companies include ODDITY Tech (ODD), Betterware de Mexico SAPI de C (BWMX), Honest (HNST), Prenetics Global (PRE), and Yatsen (YSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does USANA Health Sciences compare to ODDITY Tech?

USANA Health Sciences (NYSE:USNA) and ODDITY Tech (NASDAQ:ODD) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

ODDITY Tech has lower revenue, but higher earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than ODDITY Tech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.28	$10.76M	-$1.21	N/A
ODDITY Tech	$809.84M	1.07	$110.75M	$0.79	18.97

ODDITY Tech has a net margin of 6.97% compared to USANA Health Sciences' net margin of -2.43%. ODDITY Tech's return on equity of 15.38% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
ODDITY Tech	6.97%	15.38%	4.99%

In the previous week, ODDITY Tech had 5 more articles in the media than USANA Health Sciences. MarketBeat recorded 6 mentions for ODDITY Tech and 1 mentions for USANA Health Sciences. ODDITY Tech's average media sentiment score of 0.64 beat USANA Health Sciences' score of 0.00 indicating that ODDITY Tech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ODDITY Tech	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 35.9% of ODDITY Tech shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

USANA Health Sciences has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market. Comparatively, ODDITY Tech has a beta of 2.38, meaning that its stock price is 138% more volatile than the broader market.

ODDITY Tech has a consensus target price of $25.39, suggesting a potential upside of 69.36%. Given ODDITY Tech's stronger consensus rating and higher probable upside, analysts clearly believe ODDITY Tech is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
ODDITY Tech	4 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.69

Summary

ODDITY Tech beats USANA Health Sciences on 12 of the 15 factors compared between the two stocks.

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

USANA Health Sciences (NYSE:USNA) and Betterware de Mexico SAPI de C (NYSE:BWMX) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

Betterware de Mexico SAPI de C has a net margin of 8.35% compared to USANA Health Sciences' net margin of -2.43%. Betterware de Mexico SAPI de C's return on equity of 77.89% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
Betterware de Mexico SAPI de C	8.35%	77.89%	11.28%

Betterware de Mexico SAPI de C has lower revenue, but higher earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Betterware de Mexico SAPI de C, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.28	$10.76M	-$1.21	N/A
Betterware de Mexico SAPI de C	$744M	0.85	$55.37M	$1.83	8.70

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Betterware de Mexico SAPI de C	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

In the previous week, Betterware de Mexico SAPI de C had 1 more articles in the media than USANA Health Sciences. MarketBeat recorded 2 mentions for Betterware de Mexico SAPI de C and 1 mentions for USANA Health Sciences. Betterware de Mexico SAPI de C's average media sentiment score of 0.36 beat USANA Health Sciences' score of 0.00 indicating that Betterware de Mexico SAPI de C is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Betterware de Mexico SAPI de C	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

USANA Health Sciences has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market. Comparatively, Betterware de Mexico SAPI de C has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market.

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 12.7% of Betterware de Mexico SAPI de C shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Betterware de Mexico SAPI de C beats USANA Health Sciences on 12 of the 15 factors compared between the two stocks.

How does USANA Health Sciences compare to Honest?

Honest (NASDAQ:HNST) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

Honest presently has a consensus target price of $4.84, indicating a potential downside of 15.97%. Given Honest's stronger consensus rating and higher probable upside, equities research analysts plainly believe Honest is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Honest	2 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.22
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Honest has a beta of 2.12, suggesting that its stock price is 112% more volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market.

45.5% of Honest shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 9.4% of Honest shares are owned by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

USANA Health Sciences has higher revenue and earnings than Honest. Honest is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Honest	$371.32M	1.71	-$15.69M	-$0.11	N/A
USANA Health Sciences	$925.26M	0.28	$10.76M	-$1.21	N/A

USANA Health Sciences has a net margin of -2.43% compared to Honest's net margin of -3.56%. Honest's return on equity of 4.31% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Honest	-3.56%	4.31%	3.33%
USANA Health Sciences	-2.43%	3.41%	2.50%

In the previous week, Honest had 20 more articles in the media than USANA Health Sciences. MarketBeat recorded 21 mentions for Honest and 1 mentions for USANA Health Sciences. Honest's average media sentiment score of 0.83 beat USANA Health Sciences' score of 0.00 indicating that Honest is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Honest	13 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Honest beats USANA Health Sciences on 12 of the 17 factors compared between the two stocks.

How does USANA Health Sciences compare to Prenetics Global?

USANA Health Sciences (NYSE:USNA) and Prenetics Global (NASDAQ:PRE) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

USANA Health Sciences has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.26, indicating that its share price is 74% less volatile than the broader market.

Prenetics Global has a consensus target price of $34.80, suggesting a potential upside of 32.57%. Given Prenetics Global's stronger consensus rating and higher probable upside, analysts plainly believe Prenetics Global is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

USANA Health Sciences has higher revenue and earnings than Prenetics Global. USANA Health Sciences is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.28	$10.76M	-$1.21	N/A
Prenetics Global	$154.59M	2.87	-$37.71M	-$4.16	N/A

In the previous week, Prenetics Global had 35 more articles in the media than USANA Health Sciences. MarketBeat recorded 36 mentions for Prenetics Global and 1 mentions for USANA Health Sciences. Prenetics Global's average media sentiment score of 0.57 beat USANA Health Sciences' score of 0.00 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Prenetics Global	7 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

USANA Health Sciences has a net margin of -2.43% compared to Prenetics Global's net margin of -47.43%. USANA Health Sciences' return on equity of 3.41% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
Prenetics Global	-47.43%	-21.41%	-15.56%

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 25.0% of Prenetics Global shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Comparatively, 7.8% of Prenetics Global shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

USANA Health Sciences and Prenetics Global tied by winning 8 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Yatsen?

Yatsen (NYSE:YSG) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

USANA Health Sciences has higher revenue and earnings than Yatsen. Yatsen is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yatsen	$614.62M	0.46	-$11.56M	-$0.21	N/A
USANA Health Sciences	$925.26M	0.28	$10.76M	-$1.21	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yatsen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

USANA Health Sciences has a net margin of -2.43% compared to Yatsen's net margin of -3.04%. USANA Health Sciences' return on equity of 3.41% beat Yatsen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Yatsen	-3.04%	-4.54%	-3.49%
USANA Health Sciences	-2.43%	3.41%	2.50%

Yatsen has a beta of -1.55, indicating that its share price is 255% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market.

54.3% of USANA Health Sciences shares are owned by institutional investors. 29.0% of Yatsen shares are owned by insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Yatsen had 1 more articles in the media than USANA Health Sciences. MarketBeat recorded 2 mentions for Yatsen and 1 mentions for USANA Health Sciences. Yatsen's average media sentiment score of 0.50 beat USANA Health Sciences' score of 0.00 indicating that Yatsen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Yatsen	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

USANA Health Sciences beats Yatsen on 8 of the 13 factors compared between the two stocks.

Get USANA Health Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

USNA vs. The Competition

Export

Metric	USANA Health Sciences	Personal Care Products Industry	Consumer Staples Sector	NYSE Exchange
Market Cap	$252.57M	$23.66B	$16.07B	$24.32B
Dividend Yield	N/A	4.24%	3.19%	3.71%
P/E Ratio	-11.63	19.70	13.63	30.24
Price / Sales	0.28	13.50	263,621.38	24.16
Price / Cash	3.31	28.78	57.54	33.18
Price / Book	0.49	2.99	4.47	7.68
Net Income	$10.76M	$1.13B	$838.96M	$1.07B
7 Day Performance	4.45%	2.16%	-0.01%	-0.30%
1 Month Performance	-39.41%	3.24%	0.95%	1.63%
1 Year Performance	-55.31%	-16.68%	12.73%	14.07%

USANA Health Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
USNA USANA Health Sciences	1.2898 of 5 stars	$14.07 +2.9%	N/A	-56.2%	$252.57M	$925.26M	N/A	1,570
ODD ODDITY Tech	2.8379 of 5 stars	$12.09 -7.8%	$25.39 +110.0%	-75.2%	$754.81M	$739.71M	15.30	342
BWMX Betterware de Mexico SAPI de C	4.0268 of 5 stars	$15.97 -2.9%	N/A	+18.8%	$613.91M	$744M	8.73	2,441
HNST Honest	2.6078 of 5 stars	$4.70 -2.9%	$4.84 +3.0%	+44.7%	$532.78M	$371.32M	N/A	190
PRE Prenetics Global	4.2915 of 5 stars	$19.37 -1.9%	$34.25 +76.8%	+254.7%	$333.26M	$92.39M	N/A	1	Trending News Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:USNA) was last updated on 8/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

USANA Health Sciences (USNA) Competitors

USNA vs. ODD, BWMX, HNST, PRE, and YSG

How does USANA Health Sciences compare to ODDITY Tech?

Summary

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

Summary

How does USANA Health Sciences compare to Honest?

Summary

How does USANA Health Sciences compare to Prenetics Global?

Summary

How does USANA Health Sciences compare to Yatsen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

USANA Health Sciences (USNA) Competitors

USNA vs. ODD, BWMX, HNST, PRE, and YSG

How does USANA Health Sciences compare to ODDITY Tech?

Which has preferable earnings and valuation, USNA or ODD?

Is USNA or ODD more profitable?

Does the media refer more to USNA or ODD?

Do insiders and institutionals have more ownership in USNA or ODD?

Which has more volatility and risk, USNA or ODD?

Do analysts rate USNA or ODD?

Summary

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

Is USNA or BWMX more profitable?

Which has preferable earnings & valuation, USNA or BWMX?

Do analysts prefer USNA or BWMX?

Does the media refer more to USNA or BWMX?

Which has more volatility and risk, USNA or BWMX?

Do institutionals and insiders have more ownership in USNA or BWMX?

Summary

How does USANA Health Sciences compare to Honest?

Do analysts rate HNST or USNA?

Which has more volatility & risk, HNST or USNA?

Do institutionals and insiders believe in HNST or USNA?

Which has preferable valuation and earnings, HNST or USNA?

Is HNST or USNA more profitable?

Does the media favor HNST or USNA?

Summary

How does USANA Health Sciences compare to Prenetics Global?

Which has more volatility & risk, USNA or PRE?

Do analysts rate USNA or PRE?

Which has preferable valuation and earnings, USNA or PRE?

Does the media refer more to USNA or PRE?

Is USNA or PRE more profitable?

Do insiders & institutionals have more ownership in USNA or PRE?

Summary

How does USANA Health Sciences compare to Yatsen?

Which has higher valuation & earnings, YSG or USNA?

Do analysts recommend YSG or USNA?

Is YSG or USNA more profitable?

Which has more risk and volatility, YSG or USNA?

Do insiders and institutionals believe in YSG or USNA?

Does the media prefer YSG or USNA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools